Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-07-11
Original SEC Filing: Click here

---

Webplus: SVA/20190711/6-K/2_EX-99.1/000.htm SEC Original: tv525045_ex99-1.htm
Sinovac Reports Unaudited First Quarter 2019 Financial Results BEIJING, China, July 10, 2019 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first quarter ended March 31, 2019. First Quarter of 2019 Financial Summary Ÿ Sales for the first quarter of 2019

---

---

Webplus: SVA/20190711/6-K/1/000.htm SEC Original: tv525045_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-07-11CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200